FDA Watch: FDA Approves Enhanced Cologuard Cancer Test
Test maker Exact Sciences says it expects Cologuard Plus to cut false positives by more than 30 percent
Keeps You Up-to-Date on Federal & State Laws, Regulations, New Legislation, and Court Cases that Affect Your Diagnostic Lab or Pathology Practice
Test maker Exact Sciences says it expects Cologuard Plus to cut false positives by more than 30 percent
From - National Intelligence Report
A $3.9 million settlement arising from a potential HIPAA breach and an announcement regarding a U.S. Department of Health and Human Services Task Force emphasize the…
From - National Intelligence Report
Few dispute the promise of personalized—or, more recently, "precision"—medicine, but in a world where…
From - National Intelligence Report
Despite the looming challenges of a proposed overhaul of the Medicare payment system for clinical laboratory services and…